Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TechForce Robotics Accepted into NVIDIA Connect Program, Strengthening Position in AI-Driven Hospitality Automation
-
IperionX – September 2025 Quarterly Report
-
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
-
Amaze Expands Into the Metaverse Through Strategic Partnership with Dubit
-
GlobalFoundries and Silicon Labs Expand Partnership to Accelerate Wireless Connectivity Solutions and Strengthen U.S. Chip Manufacturing
-
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
-
Aether Holdings to Showcase Cutting-Edge Sentiment Analytics at Hong Kong FinTech Week 2025
-
Capital Clean Energy Carriers Corp. Announces Third Quarter 2025 Financial Results
-
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
-
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
-
Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer
-
Itron Announces Third Quarter 2025 Financial Results
-
Stingray Acquires DMI, Adding 8,500 Locations to its U.S. In-Store Audio Advertising Network
-
Mobile Infrastructure Closes $100 Million Asset-Backed Securitization
-
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
-
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
-
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
-
MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) Emerging as Leader in New Frontier of Natural Hydrogen as Energy Source
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) at Forefront of Effort to Optimize Next-Generation Cancer Therapies
-
Aterian Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call
-
Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution
-
Aembit Introduces Identity and Access Management for Agentic AI
-
Taylor Carr Named President of Allied Universal Technology Services
-
Bridge Investment Group Raises More than $2 Billion for Bridge Debt Strategies V
-
Inuvo to Host Third Quarter 2025 Financial Results Conference Call on Thursday, November 6th at 4:15 P.M. ET
-
Materialise to Hold Extraordinary Shareholders’ Meeting on November 14, 2025
-
Publication of Prospectus
-
Capstone Asset Management Launches Canada's First Biblically Informed ETFs on Toronto Stock Exchange
-
Freddie Mac Announces Third Quarter 2025 Financial Results
-
Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA
-
FTSE Russell and StepStone Group launch global fund-level daily private market indices
-
Bridger Aerospace Announces Schedule for its Third Quarter 2025 Earnings Release and Conference Call
-
FTC Solar to Announce Third Quarter 2025 Financial Results Wednesday, November 12, 2025
-
SONORO GOLD COMPLETES FINAL CONCESSION PAYMENT AND PROVIDES CORPORATE UPDATE
-
Next-Generation of Optical Ethernet PHY Transceivers Deliver Precision Time Protocol and MACsec Encryption for Long-Reach Networking
-
Altanine Strengthens Scientific Advisory Board with Appointment of Dr. Bruce D. Forrest
-
First Mid Bancshares, Inc. Announces Third Quarter 2025 Results
-
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
-
First Mid Bancshares, Inc. Announces Acquisition of Two Rivers Financial Group, Inc.
-
Nespresso Invites Coffee Lovers to Taste the Magic
-
Cloudbrink Brings Secure, Compliant, High-Performance AI to Enterprises
-
Cumulus Media Reports Operating Results for the Third Quarter 2025
-
Glass House Brands to Host Third Quarter 2025 Earnings Call on November 12, 2025
-
Blaqclouds Announces Multi-Chain Integration and November 3rd Relaunch of ZEUSx.io DEX
-
Consumers Are Open to AI in Healthcare if Human-Guided & Transparent, New Zyter|TruCare Survey Reveals
-
Diabetes Canada launches campaign to combat harmful myths and misinformation
-
BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
-
Veru Announces Pricing of $25 Million Public Offering
-
Lifetime Brands Announces Third Quarter 2025 Financial Results Release Date and Conference Call
-
Rumble Announces Timing of Third Quarter 2025 Earnings Release and Conference Call

